CLX Medical, Inc. Announces a Definitive Agreement for the …
September 15th, 2008 : Category: Medical newsApproximately 120 million thyroid-related lab tests are performed in
the United States each year. At an estimated average cost of $40 per
test, the U.S. market is currently valued at nearly $5 billion.
Approximately 45 million of those tests are conducted in order to
diagnose thyroid dysfunction. CLX believes that ThyroTest(R) is an
appropriate, cost-effective first-step for those 45 million diagnostic
TSH tests. This current U.S. market opportunity Read the rest of this entry »